Chemobiodynamics Laboratory, Department of Chemistry, Faculty of Sciences , University of Chile , Santiago 7900003 , Chile.
Laboratory of Neuropharmacology and Behavior, School of Medicine, Faculty of Medical Sciences , Universidad de Santiago de Chile , Santiago 9170022 , Chile.
ACS Chem Neurosci. 2018 Oct 17;9(10):2448-2458. doi: 10.1021/acschemneuro.8b00215. Epub 2018 Jun 8.
Archeological studies in the United States, Mexico, and Peru suggest that mescaline, as a cactus constituent, has been used for more than 6000 years. Although it is a widespread cactus alkaloid, it is present in high concentrations in few species, notably the North American peyote ( Lophophora williamsii) and the South American wachuma ( Trichocereus pachanoi, T. peruvianus, and T. bridgesii). Spanish 16th century chroniclers considered these cacti "diabolic", leading to their prohibition, but their use persisted to our days and has been spreading for the last 150 years. In the late 1800s, peyote attracted scientific attention; mescaline was isolated, and its role in the psychedelic effects of peyote tops or "mescal buttons" was demonstrated. Its structure was established by synthesis in 1929, and alternative routes were developed, providing larger amounts for pharmacological and biosynthetic research. Although its effects are attributed mainly to its action as a 5-HT serotonin receptor agonist, mescaline binds in a similar concentration range to 5-HT and α receptors. It is largely excreted unchanged in human urine, and its metabolic products are apparently unrelated to its psychedelic properties. Its low potency is probably responsible for its relative neglect by recreational substance users, as the successful search for structure-activity relationships in the hallucinogen field focused largely on finding more potent analogues. Renewed interest in the possible therapeutic applications of psychedelic drugs may hopefully lead to novel insights regarding the commonalities and differences between the actions of individual classic hallucinogens.
考古研究表明,在墨西哥和秘鲁,作为仙人掌成分的三甲氧苯乙胺已经使用了超过 6000 年。虽然它是一种广泛存在的仙人掌生物碱,但它在少数物种中浓度很高,特别是北美的仙人球(Lophophora williamsii)和南美的瓦哈卡( Trichocereus pachanoi、T. peruvianus 和 T. bridgesii)。16 世纪的西班牙编年史家认为这些仙人掌是“恶魔”,导致它们被禁止,但它们的使用一直持续到今天,并在过去的 150 年里传播开来。19 世纪后期,仙人球引起了科学界的注意;三甲氧苯乙胺被分离出来,并证明了它在仙人球顶部或“三甲氧苯乙胺纽扣”的迷幻作用中的作用。1929 年通过合成确定了其结构,并开发了替代途径,为药理学和生物合成研究提供了更多的物质。尽管其作用主要归因于其作为 5-HT 血清素受体激动剂的作用,但三甲氧苯乙胺在类似浓度范围内与 5-HT 和α受体结合。它在人类尿液中主要以不变的形式排泄,其代谢产物显然与其迷幻特性无关。其低效力可能是其被娱乐性物质使用者忽视的主要原因,因为在迷幻剂领域寻找结构-活性关系的成功研究主要集中在寻找更有效的类似物上。对迷幻药物可能的治疗应用的重新关注,有望为个体经典迷幻剂的作用的异同提供新的见解。